_id
69105bd1ccc777a4e85d581d
Ticker
DMPHF
Name
Dermapharm Holding SE
Exchange
PINK
Address
Lil-Dagover-Ring 7, Grünwald, Germany, 82031
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://ir.dermapharm.de
Description
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
Last Close
42.684
Volume
476
Current Price
39.56
Change
0
Last Updated
2026-01-02T12:41:25.509Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
2129910528
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
346049802
Cost Of Revenue
219933165
Gross Profit
126116637
Operating Expenses
50017880
Operating Income
76098757
Interest Expense
17229619
Pretax Income
64724603
Net Income
48375064
Eps
0.8984967310549777
Dividends Per Share
56860208
Shares Outstanding
53840000
Income Tax Expense
16486832
EBITDA
106637533
Operating Margin
21.99069514277601
Total Other Income Expense Net
-11374154
Cash
171998141
Short Term Investments
-
Receivables
153810994
Inventories
398599966
Total Current Assets
754976041
Property Plant Equipment
367104836
Total Assets
2484202989
Payables
110121476
Short Term Debt
90946293
Long Term Debt
-
Total Liabilities
1725753565
Equity
761824237
Bs_currency_symbol
-
Depreciation
24698565
Change In Working Capital
1555981
Cash From Operations
52135939
Capital Expenditures
11402316
Cash From Investing
-22784684
Cash From Financing
-48375064
Net Change In Cash
-19644340
Cf_currency_symbol
-
PE
17.9005
PB
2.7958028854364216
ROE
6.349898264000756
ROA
1.9473072133881084
FCF
40733623
Fcf Percent
0.11771029130656749
Piotroski FScore
4
Health Score
54
Deep Value Investing Score
4
Defensive Investing Score
5.5
Dividend Investing Score
3.5
Economic Moat Investing Score
6.8
Garp Investing Score
6.5
Growth Investing Score
6.5
Momentum Investing Score
4
Net Net Investing Score
4
Quality Investing Score
5.5
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
346049802
Quarters > 0 > income Statement > cost Of Revenue
219933165
Quarters > 0 > income Statement > gross Profit
126116637
Quarters > 0 > income Statement > operating Expenses
50017880
Quarters > 0 > income Statement > operating Income
76098757
Quarters > 0 > income Statement > interest Expense
17229619
Quarters > 0 > income Statement > pretax Income
64724603
Quarters > 0 > income Statement > net Income
48375064
Quarters > 0 > income Statement > eps
0.8984967310549777
Quarters > 0 > income Statement > dividends Per Share
56860208
Quarters > 0 > income Statement > shares Outstanding
53840000
Quarters > 0 > income Statement > income Tax Expense
16486832
Quarters > 0 > income Statement > EBITDA
106637533
Quarters > 0 > income Statement > operating Margin
21.99069514277601
Quarters > 0 > income Statement > total Other Income Expense Net
-11374154
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
171998141
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
153810994
Quarters > 0 > balance Sheet > inventories
398599966
Quarters > 0 > balance Sheet > total Current Assets
754976041
Quarters > 0 > balance Sheet > property Plant Equipment
367104836
Quarters > 0 > balance Sheet > total Assets
2484202989
Quarters > 0 > balance Sheet > payables
110121476
Quarters > 0 > balance Sheet > short Term Debt
90946293
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1725753565
Quarters > 0 > balance Sheet > equity
761824237
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
48375064
Quarters > 0 > cash Flow > depreciation
24698565
Quarters > 0 > cash Flow > change In Working Capital
1555981
Quarters > 0 > cash Flow > cash From Operations
52135939
Quarters > 0 > cash Flow > capital Expenditures
11402316
Quarters > 0 > cash Flow > cash From Investing
-22784684
Quarters > 0 > cash Flow > cash From Financing
-48375064
Quarters > 0 > cash Flow > net Change In Cash
-19644340
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.8984967310549777
Quarters > 0 > ratios > PB
2.7958028854364216
Quarters > 0 > ratios > ROE
6.349898264000756
Quarters > 0 > ratios > ROA
1.9473072133881084
Quarters > 0 > ratios > FCF
40733623
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.11771029130656749
Quarters > 0 > health Score
54
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
272146000
Quarters > 1 > income Statement > cost Of Revenue
88015000
Quarters > 1 > income Statement > gross Profit
184131000
Quarters > 1 > income Statement > operating Expenses
139645000
Quarters > 1 > income Statement > operating Income
44486000
Quarters > 1 > income Statement > interest Expense
13177000
Quarters > 1 > income Statement > pretax Income
32526000
Quarters > 1 > income Statement > net Income
20894000
Quarters > 1 > income Statement > eps
0.38999999981334355
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
53574359
Quarters > 1 > income Statement > income Tax Expense
11633000
Quarters > 1 > income Statement > EBITDA
66059000
Quarters > 1 > income Statement > operating Margin
16.346372902780125
Quarters > 1 > income Statement > total Other Income Expense Net
-11960000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
162686000
Quarters > 1 > balance Sheet > short Term Investments
3212000
Quarters > 1 > balance Sheet > receivables
117555000
Quarters > 1 > balance Sheet > inventories
350324000
Quarters > 1 > balance Sheet > total Current Assets
662585000
Quarters > 1 > balance Sheet > property Plant Equipment
314602000
Quarters > 1 > balance Sheet > total Assets
2135540000
Quarters > 1 > balance Sheet > payables
100738000
Quarters > 1 > balance Sheet > short Term Debt
84613000
Quarters > 1 > balance Sheet > long Term Debt
910931000
Quarters > 1 > balance Sheet > total Liabilities
1530052000
Quarters > 1 > balance Sheet > equity
608248000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
32526000
Quarters > 1 > cash Flow > depreciation
20056000
Quarters > 1 > cash Flow > change In Working Capital
15924000
Quarters > 1 > cash Flow > cash From Operations
65895000
Quarters > 1 > cash Flow > capital Expenditures
10442000
Quarters > 1 > cash Flow > cash From Investing
-9934000
Quarters > 1 > cash Flow > cash From Financing
-6642000
Quarters > 1 > cash Flow > net Change In Cash
47511000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
0.38999999981334355
Quarters > 1 > ratios > PB
3.484436680498744
Quarters > 1 > ratios > ROE
3.435111993792006
Quarters > 1 > ratios > ROA
0.9783942234750929
Quarters > 1 > ratios > FCF
55453000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.20376195130554922
Quarters > 1 > health Score
54
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
302396000
Quarters > 2 > income Statement > cost Of Revenue
103211000
Quarters > 2 > income Statement > gross Profit
199185000
Quarters > 2 > income Statement > operating Expenses
139397000
Quarters > 2 > income Statement > operating Income
59788000
Quarters > 2 > income Statement > interest Expense
12877000
Quarters > 2 > income Statement > pretax Income
49667000
Quarters > 2 > income Statement > net Income
33405000
Quarters > 2 > income Statement > eps
0.6200000029696153
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
53879032
Quarters > 2 > income Statement > income Tax Expense
16470000
Quarters > 2 > income Statement > EBITDA
82530000
Quarters > 2 > income Statement > operating Margin
19.771425547956984
Quarters > 2 > income Statement > total Other Income Expense Net
-10121000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
115176000
Quarters > 2 > balance Sheet > short Term Investments
2841000
Quarters > 2 > balance Sheet > receivables
129440000
Quarters > 2 > balance Sheet > inventories
350681000
Quarters > 2 > balance Sheet > total Current Assets
630240000
Quarters > 2 > balance Sheet > property Plant Equipment
316451000
Quarters > 2 > balance Sheet > total Assets
2111738000
Quarters > 2 > balance Sheet > payables
97517000
Quarters > 2 > balance Sheet > short Term Debt
79509000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1469512000
Quarters > 2 > balance Sheet > equity
638560000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
49667000
Quarters > 2 > cash Flow > depreciation
19953000
Quarters > 2 > cash Flow > change In Working Capital
-40157000
Quarters > 2 > cash Flow > cash From Operations
4228000
Quarters > 2 > cash Flow > capital Expenditures
10074000
Quarters > 2 > cash Flow > cash From Investing
-9298000
Quarters > 2 > cash Flow > cash From Financing
-145000
Quarters > 2 > cash Flow > net Change In Cash
-6110000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
0.6200000029696153
Quarters > 2 > ratios > PB
3.3379079584064146
Quarters > 2 > ratios > ROE
5.231301678777249
Quarters > 2 > ratios > ROA
1.5818723724249881
Quarters > 2 > ratios > FCF
-5846000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
-0.01933226629981878
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
290670000
Quarters > 3 > income Statement > cost Of Revenue
97491000
Quarters > 3 > income Statement > gross Profit
193179000
Quarters > 3 > income Statement > operating Expenses
145323000
Quarters > 3 > income Statement > operating Income
47856000
Quarters > 3 > income Statement > interest Expense
11530000
Quarters > 3 > income Statement > pretax Income
34553000
Quarters > 3 > income Statement > net Income
20508000
Quarters > 3 > income Statement > eps
0.3800416956219597
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
53962500
Quarters > 3 > income Statement > income Tax Expense
15503000
Quarters > 3 > income Statement > EBITDA
72244000
Quarters > 3 > income Statement > operating Margin
16.464031375786973
Quarters > 3 > income Statement > total Other Income Expense Net
-13303000
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
121195000
Quarters > 3 > balance Sheet > short Term Investments
511000
Quarters > 3 > balance Sheet > receivables
105005000
Quarters > 3 > balance Sheet > inventories
339856000
Quarters > 3 > balance Sheet > total Current Assets
593498000
Quarters > 3 > balance Sheet > property Plant Equipment
315028000
Quarters > 3 > balance Sheet > total Assets
2080019000
Quarters > 3 > balance Sheet > payables
94785000
Quarters > 3 > balance Sheet > short Term Debt
89935000
Quarters > 3 > balance Sheet > long Term Debt
877330000
Quarters > 3 > balance Sheet > total Liabilities
1471724000
Quarters > 3 > balance Sheet > equity
604422000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
34553000
Quarters > 3 > cash Flow > depreciation
24489000
Quarters > 3 > cash Flow > change In Working Capital
26815000
Quarters > 3 > cash Flow > cash From Operations
71724000
Quarters > 3 > cash Flow > capital Expenditures
11879000
Quarters > 3 > cash Flow > cash From Investing
-7570000
Quarters > 3 > cash Flow > cash From Financing
-62056000
Quarters > 3 > cash Flow > net Change In Cash
2970000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
0.3800416956219597
Quarters > 3 > ratios > PB
3.5318974160437575
Quarters > 3 > ratios > ROE
3.392993636896076
Quarters > 3 > ratios > ROA
0.9859525321643697
Quarters > 3 > ratios > FCF
59845000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.2058864003853167
Quarters > 3 > health Score
54
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1180766000
Annuals > 0 > income Statement > cost Of Revenue
413696000
Annuals > 0 > income Statement > gross Profit
767070000
Annuals > 0 > income Statement > operating Expenses
550137000
Annuals > 0 > income Statement > operating Income
216933000
Annuals > 0 > income Statement > interest Expense
58408000
Annuals > 0 > income Statement > pretax Income
172005000
Annuals > 0 > income Statement > net Income
113787000
Annuals > 0 > income Statement > eps
2.1086309937456567
Annuals > 0 > income Statement > dividends Per Share
47379000
Annuals > 0 > income Statement > shares Outstanding
53962500
Annuals > 0 > income Statement > income Tax Expense
60268000
Annuals > 0 > income Statement > EBITDA
320908000
Annuals > 0 > income Statement > operating Margin
18.37222616504879
Annuals > 0 > income Statement > total Other Income Expense Net
-44928000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
121195000
Annuals > 0 > balance Sheet > short Term Investments
511000
Annuals > 0 > balance Sheet > receivables
105005000
Annuals > 0 > balance Sheet > inventories
339856000
Annuals > 0 > balance Sheet > total Current Assets
593498000
Annuals > 0 > balance Sheet > property Plant Equipment
315028000
Annuals > 0 > balance Sheet > total Assets
2080019000
Annuals > 0 > balance Sheet > payables
94785000
Annuals > 0 > balance Sheet > short Term Debt
89935000
Annuals > 0 > balance Sheet > long Term Debt
877330000
Annuals > 0 > balance Sheet > total Liabilities
1471724000
Annuals > 0 > balance Sheet > equity
604422000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
172005000
Annuals > 0 > cash Flow > depreciation
86785000
Annuals > 0 > cash Flow > change In Working Capital
-18056000
Annuals > 0 > cash Flow > cash From Operations
201378000
Annuals > 0 > cash Flow > capital Expenditures
38237000
Annuals > 0 > cash Flow > cash From Investing
-29614000
Annuals > 0 > cash Flow > cash From Financing
-209169000
Annuals > 0 > cash Flow > net Change In Cash
-37440000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
2.1086309937456567
Annuals > 0 > ratios > PB
3.5318974160437575
Annuals > 0 > ratios > ROE
18.82575419160785
Annuals > 0 > ratios > ROA
5.47047887543335
Annuals > 0 > ratios > FCF
163141000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.13816539432876623
Annuals > 0 > health Score
64
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1150741000
Annuals > 1 > income Statement > cost Of Revenue
446597000
Annuals > 1 > income Statement > gross Profit
704144000
Annuals > 1 > income Statement > operating Expenses
521250000
Annuals > 1 > income Statement > operating Income
182894000
Annuals > 1 > income Statement > interest Expense
54968000
Annuals > 1 > income Statement > pretax Income
105997000
Annuals > 1 > income Statement > net Income
62368000
Annuals > 1 > income Statement > eps
1.1583952451708768
Annuals > 1 > income Statement > dividends Per Share
56532000
Annuals > 1 > income Statement > shares Outstanding
53840000
Annuals > 1 > income Statement > income Tax Expense
45462000
Annuals > 1 > income Statement > EBITDA
262737000
Annuals > 1 > income Statement > operating Margin
15.893585089955081
Annuals > 1 > income Statement > total Other Income Expense Net
-76897000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
158724000
Annuals > 1 > balance Sheet > short Term Investments
818000
Annuals > 1 > balance Sheet > receivables
95406000
Annuals > 1 > balance Sheet > inventories
317406000
Annuals > 1 > balance Sheet > total Current Assets
630496000
Annuals > 1 > balance Sheet > property Plant Equipment
330771000
Annuals > 1 > balance Sheet > total Assets
2160673000
Annuals > 1 > balance Sheet > payables
86641000
Annuals > 1 > balance Sheet > short Term Debt
116430000
Annuals > 1 > balance Sheet > long Term Debt
950705000
Annuals > 1 > balance Sheet > total Liabilities
1615625000
Annuals > 1 > balance Sheet > equity
539207000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
62368000
Annuals > 1 > cash Flow > depreciation
101772000
Annuals > 1 > cash Flow > change In Working Capital
9042000
Annuals > 1 > cash Flow > cash From Operations
219422000
Annuals > 1 > cash Flow > capital Expenditures
41541000
Annuals > 1 > cash Flow > cash From Investing
-415432000
Annuals > 1 > cash Flow > cash From Financing
204538000
Annuals > 1 > cash Flow > net Change In Cash
7696000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
1.1583952451708768
Annuals > 1 > ratios > PB
3.9500792830953606
Annuals > 1 > ratios > ROE
11.566615418568379
Annuals > 1 > ratios > ROA
2.886508046335563
Annuals > 1 > ratios > FCF
177881000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.15457952745231116
Annuals > 1 > health Score
56
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1024776000
Annuals > 2 > income Statement > cost Of Revenue
363943000
Annuals > 2 > income Statement > gross Profit
660833000
Annuals > 2 > income Statement > operating Expenses
418784000
Annuals > 2 > income Statement > operating Income
243687000
Annuals > 2 > income Statement > interest Expense
14840086
Annuals > 2 > income Statement > pretax Income
216297000
Annuals > 2 > income Statement > net Income
134236000
Annuals > 2 > income Statement > eps
2.4932392273402675
Annuals > 2 > income Statement > dividends Per Share
116833000
Annuals > 2 > income Statement > shares Outstanding
53840000
Annuals > 2 > income Statement > income Tax Expense
83680000
Annuals > 2 > income Statement > EBITDA
323544000
Annuals > 2 > income Statement > operating Margin
23.77953816248624
Annuals > 2 > income Statement > total Other Income Expense Net
-27390000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
149918000
Annuals > 2 > balance Sheet > short Term Investments
11440000
Annuals > 2 > balance Sheet > receivables
100149000
Annuals > 2 > balance Sheet > inventories
251822000
Annuals > 2 > balance Sheet > total Current Assets
533947000
Annuals > 2 > balance Sheet > property Plant Equipment
225673000
Annuals > 2 > balance Sheet > total Assets
1412836000
Annuals > 2 > balance Sheet > payables
56100000
Annuals > 2 > balance Sheet > short Term Debt
4887000
Annuals > 2 > balance Sheet > long Term Debt
501845000
Annuals > 2 > balance Sheet > total Liabilities
880344000
Annuals > 2 > balance Sheet > equity
531592000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
216297000
Annuals > 2 > cash Flow > depreciation
94909000
Annuals > 2 > cash Flow > change In Working Capital
-4138000
Annuals > 2 > cash Flow > cash From Operations
288533000
Annuals > 2 > cash Flow > capital Expenditures
39014000
Annuals > 2 > cash Flow > cash From Investing
-99008000
Annuals > 2 > cash Flow > cash From Financing
-199768000
Annuals > 2 > cash Flow > net Change In Cash
-10395000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
2.4932392273402675
Annuals > 2 > ratios > PB
4.006663757167151
Annuals > 2 > ratios > ROE
25.251696790019412
Annuals > 2 > ratios > ROA
9.501173526155902
Annuals > 2 > ratios > FCF
249519000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.24348638141408463
Annuals > 2 > health Score
79
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
942912000
Annuals > 3 > income Statement > cost Of Revenue
322218000
Annuals > 3 > income Statement > gross Profit
620694000
Annuals > 3 > income Statement > operating Expenses
333651000
Annuals > 3 > income Statement > operating Income
298469000
Annuals > 3 > income Statement > interest Expense
8837000
Annuals > 3 > income Statement > pretax Income
292977000
Annuals > 3 > income Statement > net Income
209583000
Annuals > 3 > income Statement > eps
3.8927005943536406
Annuals > 3 > income Statement > dividends Per Share
47379000
Annuals > 3 > income Statement > shares Outstanding
53840000
Annuals > 3 > income Statement > income Tax Expense
84073000
Annuals > 3 > income Statement > EBITDA
356973000
Annuals > 3 > income Statement > operating Margin
31.653961345279303
Annuals > 3 > income Statement > total Other Income Expense Net
-5492000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
160319000
Annuals > 3 > balance Sheet > short Term Investments
11742000
Annuals > 3 > balance Sheet > receivables
76083000
Annuals > 3 > balance Sheet > inventories
240535000
Annuals > 3 > balance Sheet > total Current Assets
519222000
Annuals > 3 > balance Sheet > property Plant Equipment
222287000
Annuals > 3 > balance Sheet > total Assets
1406969000
Annuals > 3 > balance Sheet > payables
52101000
Annuals > 3 > balance Sheet > short Term Debt
5580000
Annuals > 3 > balance Sheet > long Term Debt
565708000
Annuals > 3 > balance Sheet > total Liabilities
907135000
Annuals > 3 > balance Sheet > equity
497316000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
292977000
Annuals > 3 > cash Flow > depreciation
55159000
Annuals > 3 > cash Flow > change In Working Capital
-46271000
Annuals > 3 > cash Flow > cash From Operations
250368000
Annuals > 3 > cash Flow > capital Expenditures
61203000
Annuals > 3 > cash Flow > cash From Investing
-129347000
Annuals > 3 > cash Flow > cash From Financing
-80979000
Annuals > 3 > cash Flow > net Change In Cash
41114000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
3.8927005943536406
Annuals > 3 > ratios > PB
4.282810929067233
Annuals > 3 > ratios > ROE
42.142822672103854
Annuals > 3 > ratios > ROA
14.896063808086746
Annuals > 3 > ratios > FCF
189165000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.20061787314192628
Annuals > 3 > health Score
79
Valuation > metrics > PE
17.9005
Valuation > metrics > PB
2.7958028854364216
Valuation > final Score
100
Valuation > verdict
Fair
Profitability > metrics > ROE
6.349898264000756
Profitability > metrics > ROA
6.407496579086806
Profitability > metrics > Net Margin
0.13979220251078195
Profitability > final Score
53
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.265290970258275
Risk > metrics > Interest Coverage
4.416740555899698
Risk > final Score
36
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.754833729716273
Liquidity > metrics > Quick Ratio
1.772417711562712
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
65.15563319501256
Prev Valuations > 1
66.62092041593586
Prev Valuations > 2
64.68102583956242
Prev Profitabilities > 0
28
Prev Profitabilities > 1
43
Prev Profitabilities > 2
28
Prev Risks > 0
32
Prev Risks > 1
37
Prev Risks > 2
35
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:43:05.932Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-31
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2022-06-30
Earnings History > 1 > report Date
2022-08-31
Earnings History > 1 > date
2022-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
0.27
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-03-31
Earnings History > 2 > report Date
2022-04-11
Earnings History > 2 > date
2022-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
0.69
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2021-09-30
Earnings History > 3 > report Date
2021-11-15
Earnings History > 3 > date
2021-09-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
1.15
Earnings History > 3 > eps Estimate
0.98
Earnings History > 3 > eps Difference
0.17
Earnings History > 3 > surprise Percent
17.3469
Earnings History > 4 > period
2021-06-30
Earnings History > 4 > report Date
2021-09-06
Earnings History > 4 > date
2021-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.74
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-03-31
Earnings History > 5 > report Date
2021-05-17
Earnings History > 5 > date
2021-03-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.67
Earnings History > 5 > eps Estimate
0.59
Earnings History > 5 > eps Difference
0.08
Earnings History > 5 > surprise Percent
13.5593
Earnings History > 6 > period
2020-09-30
Earnings History > 6 > report Date
2020-11-15
Earnings History > 6 > date
2020-09-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.42
Earnings History > 6 > eps Estimate
0.43
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-2.3256
Earnings History > 7 > period
2020-06-30
Earnings History > 7 > report Date
2020-09-08
Earnings History > 7 > date
2020-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.22
Earnings History > 7 > eps Estimate
0.38
Earnings History > 7 > eps Difference
-0.16
Earnings History > 7 > surprise Percent
-42.1053
Earnings History > 8 > period
2019-09-30
Earnings History > 8 > report Date
2019-11-19
Earnings History > 8 > date
2019-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.36
Earnings History > 8 > eps Estimate
0.44
Earnings History > 8 > eps Difference
-0.08
Earnings History > 8 > surprise Percent
-18.1818
Earnings History > 9 > period
2019-06-30
Earnings History > 9 > report Date
2019-09-11
Earnings History > 9 > date
2019-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.38
Earnings History > 9 > eps Estimate
0.44
Earnings History > 9 > eps Difference
-0.06
Earnings History > 9 > surprise Percent
-13.6364
Earnings History > 10 > period
2019-03-31
Earnings History > 10 > report Date
2019-04-16
Earnings History > 10 > date
2019-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.36
Earnings History > 10 > eps Estimate
0.44
Earnings History > 10 > eps Difference
-0.08
Earnings History > 10 > surprise Percent
-18.1818
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Dermapharm Holding SE
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2022-06-30
EPS Actual
0.27
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.